Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin and Fish Oils in Visceral Obesity
NCT00392717Phase 3Completed
- Sponsor
- The University of Western Australia
- Start
- Feb 1998
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of atorvastatin and fish oil concentrate in obesity, dyslipidemia and insulin resistance (IR) (4 arms), sponsored by The University of Western Australia. Primary endpoints: Fractional catabolic rate of apoB, apoA, apoC-III and chylomicron remnants at 6 weeks and Production rate of apoB, apoA, apoC-III and chylomicron remnants at 6 weeks. Started Feb 1998; status: completed.
02
Drugs
atorvastatinfish oil concentrate
03
Conditions
obesitydyslipidemiainsulin resistance (IR)
Beyond the preview
Go deeper on NCT00392717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00392717.